FIELD: medicine, pediatrics, psycho-neurology.
SUBSTANCE: the present innovation deals with applying preparation that normalize energy exchange. For this purpose it is necessary to introduce L-carnitine at the dosage of 20-30 mg/kg/d in three stages, coenzyme Q10 at the dosage of 30-60 mg/d once and limontar at the dosage of 10 mg/kg/d once during the first half of the day for 2 mo twice annually. The present innovation provides improved values for nervous-psychic development due to correcting mitochondrial alterations.
EFFECT: higher efficiency of therapy.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING CHILDREN FOR POLYCYSTIC RENAL DISEASE | 2005 |
|
RU2316322C2 |
| METHOD OF PREDICTION OF MITOCHONDRIAL MALADIES IN INFANTS WITH UNDIFFERENTIATED FORMS OF NEUROPSYCHIC DELAY (VERSIONS) | 2008 |
|
RU2366959C1 |
| APPLICATION OF PERCUTANEOUS GAS EXCHANGE MONITORING FOR DIAGNOSTICS OF THE POWER SHORTAGE STATES | 2010 |
|
RU2442535C2 |
| METHOD FOR DIAGNOSIS OF DISTURBED ENERGY METABOLISM OF LYMPHOCYTES WITH COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN | 2014 |
|
RU2579317C1 |
| METHOD OF PREDICTING COURSE OF MYOCARDIAL INFARCTION BASING ON ASSESSMENT OF MITOCHONDRIAL DYSFUNCTION EXPRESSION | 2011 |
|
RU2519700C2 |
| METHOD OF TREATING CONGENITAL STRUCTURAL MYOPATHIES AND CONGENITAL MUSCULAR DYSTROPHIES BY CORRECTION OF SECONDARY MITOCHONDRIAL CHANGES | 2008 |
|
RU2400221C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF POLYSYSTEMIC MITOCHONDRIAL DEFICIENCY IN CHILDREN | 2005 |
|
RU2312347C2 |
| METHOD FOR DETERMINING THE ENERGY METABOLISM ENZYME DYSFUNCTION IN RESPIRATORY PATHOLOGY IN CHILDREN AND APPLICATION THEREOF | 2020 |
|
RU2759652C1 |
| METHOD FOR PREDICTION OF THE RISK OF LONG-TERM CELLULAR ENERGY DEFICIENCY IN INFANTS BORN IN ULTRAEARLY PRETERM DELIVERY AT THE FIRST YEAR OF LIFE | 2019 |
|
RU2701724C1 |
| METHOD OF CYTOCHEMICAL CARDIAC ADAPTATION PREDICTION IN INFANTS | 2008 |
|
RU2353935C1 |
